NEJM Group

CardioExchange Archive

CardioExchange, an NEJM practice community for medical professionals dedicated to improving cardiac patient care, was active from 2009 to 2015. CardioExchange fostered discussion between clinicians from across the globe.

March 28th, 2014

ACC.14 Headquarters

wpengine

CardioExchange is dedicated to bringing you the latest from ACC.14. Check out our coverage of the conference ─ and some of the great debates these posts have sparked ─ then tell us what you think!

News:

  • No Benefit Found in First Real Test of Renal Denervation
  • Survival Advantage for TAVR Over Surgery in High-Risk Patients
  • First TAVR Comparison Trial Favors Sapien XT Over CoreValve
  • MADIT-CRT Long-Term Follow-Up Shows Survival Benefit with CRT-D
  • High-Sensitivity Troponin Test Could Identify Low-Risk Chest Pain Patients in the ED
  • Aspirin and Clonidine Fail to Help Surgery Patients
  • Novartis Trial Was Stopped Early Because of a Significant Drop in Cardiovascular Mortality

Analysis:

  • Negative Findings on Renal Denervation for Hypertension: Sweet SYMPLICITY?
  • TAVR: Are You Impressed Now?
  • Long-Term Follow-Up from MADIT-CRT: Guideline Implications
  • Are We Equipped to Make a CHOICE Between TAVR Devices?

Follow our Fellows:

  • Changing My Priorities for ACC.14
  • Ideals Lost, But Not Stolen
  • Are Digital Conferences the Way of the Future?
  • Taking Patient-Centerdness to the Next Level at ACC.14
  • Stage Set for Phase IV Trials of PCSK9 Inhibition
  • Master of all Trades

Categories: General


You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.

  • Search the Archive

  • Archives by Date

  • RSS NEJM — Recent Cardiology Articles

    • Utah’s Prescription-Renewal Pilot Program — Autonomous AI Managing Patient Care April 23, 2026
      Utah recently rolled out a pilot program involving an AI system that autonomously renews certain prescriptions for people with chronic conditions. This program raises important clinical and legal issues.
    • Double Take: HFpEF Explained — Prevalence, New Advances, and How to Diagnose April 23, 2026
      This Double Take video reviews heart failure with preserved ejection fraction, its risk factors and causes, and the challenge in establishing the diagnosis.
    • Blood-Pressure Control after Intracerebral Hemorrhage — An Unbroken Glass Ceiling April 23, 2026
      Effective blood-pressure control is the cornerstone of management after intracerebral hemorrhage; it is both the primary determinant of risk and the most vital intervention for reducing the threat of a second vascular event.1 Yet, despite the availability of effective treatments, blood pressure remains poorly controlled in survivors of...
    • Three Low-Dose Antihypertensive Agents in a Single Pill after Intracerebral Hemorrhage April 23, 2026
      Among survivors of intracerebral hemorrhage, a single pill with three low-dose antihypertensive agents added to standard care was associated with a lower incidence of stroke and major cardiovascular events than placebo.
    • Glucocorticoids in Kawasaki Disease — Refining Indications and the Science April 16, 2026
      Kawasaki disease is the most common cause of acquired heart disease in children in the developed world.1 Although Kawasaki disease manifests with acute, transient systemic signs, its long-term morbidity derives from necrotizing vasculitis that predominantly affects the coronary arteries.2,3 The primary goal of therapy during the...
  • Tag Cloud

    • ACS AF AHA anticoagulation aortic valve replacement apixaban aspirin atrial fibrillation CABG cardiovascular risk cholesterol clopidogrel dabigatran diabetes diet drug-eluting stents epidemiology ESC exercise FDA FDA approvals Fellowship training guidelines HDL heart failure hypertension ICDs MI myocardial infarction obesity PCI Primary PCI risk factors rivaroxaban statins STEMI stents stroke stroke prevention TAVI TAVR type 2 diabetes venous thromboembolism warfarin women
NEJM Group

Copyright © 2026 Massachusetts Medical Society. All rights reserved.

The content of this site is intended for health care professionals. Copyright | Terms | Privacy Policy |